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The German Health Care Innovation Fund –
An Incentive for Innovations to Promote the Integration of Health Care
Abstract
Purpose - Many health systems face challenges such as rising costs and lacking 
quality, both of which can be addressed by improving the integration of different health 
care sectors and professions. The purpose of this viewpoint is to present the German 
health care Innovation Fund (IF) initiated by the Federal Government to support the 
development and diffusion of integrated health care. 
Design/methodology/approach - This article describes the design and rationale of 
the IF in detail and provides first insights into its limitations, acceptance and 
implementation by relevant stakeholders. 
Findings - In its first period, the IF offered € 1.2 billion as start-up funding for model 
implementation and evaluation over a period of four years (2016-2019). This period 
was recently extended to a second round until 2024, offering € 200 million a year as 
from 2020. The IF is triggering the support of relevant insurers for the development of 
new integrated care models. In addition, strict evaluation requirements have led to a 
large number of health service research projects which assess structural and process 
improvements and thus enable evidence-based policy decisions.
Originality/value - This article is the first of its kind to present the German IF to the 
international readership. The IF is a political initiative through which to foster 
innovations and promote integrated health care. 
Key words Innovation Fund; integrated care; reform initiatives; policy instrument; 
statutory sickness funds; health service research; Germany
Paper type Viewpoint 
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Introduction - The German Health Care Innovation Fund in the Context of Long-
standing Health Care Reforms in Germany
Due to the aging population and the increasing prevalence of chronic diseases and 
multiple co-morbidities, most Western governments seek to adapt health care by 
integrating services across the primary, secondary, and home care sectors and across 
health care professions (Busse and Stahl, 2014). Integrated care (IC) is meant to 
secure continuity, coordination, and appropriateness of health and health-related 
social services and thus increase quality and efficiency of care and satisfaction of 
users. IC can include a variety of services and providers to varying degrees, 
encompassing cure and care, integrating administrative and organizational issues up 
to a joint financing (Kodner and Spreeuwenberg, 2002). IC is therefore particularly 
suitable for the care of an aging population. 
Policy initiatives to foster IC have consumed noteworthy resources and lessons 
learned are that the national government, regional and local authorities should 
proactively set the agenda and encourage initiatives rather than leaving integration to 
the market (Mur-Veeman et al., 2008). Germany is a case in point, but the impact of a 
series of reforms that were introduced over the last two decades is generally seen as 
falling behind expectations (Schlette et al., 2009) [see figure 1]. While there is no 
shortage of product innovations in the German health care sector, mainly as a result 
of major investment by manufacturers, hardly any structural or process innovations 
have taken place. The health system as a whole is characterised not only by 
institutional complexities and persistence, but even by path dependencies which make 
disruptive innovations (Christensen et al., 2015) that would lead to significant system 
changes practically impossible (Sydow et al., 2009, Auschra and Sydow, 2020). Thus, 
the German social security system (see Obermann et al., 2019, Busse et al., 2017 for 
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details about the basic structure of the German health care system), which provides 
the financial foundation of most health care services in this country, is characterized 
by reactive behaviour towards inter-/cross-sectoral challenges. Because Germany 
lacks a structure at the federal level that sets binding strategic guidelines for the entire 
health care system, the steering power of the national policy is weak, and there is no 
consensus on more far-reaching agreements on change that can be implemented by 
the actors in a structured process, as is indeed possible in countries with a state health 
care system (Gilbert et al., 2015). 
Since 2000, the legislator has been trying to create targeted incentives to open the 
health care system to new forms of cooperation, delegation and digitalization, the latter 
in particular being associated with a development towards more integrated care (Lluch 
and Abadie, 2013). Initial policy initiatives included financial incentives for statutory 
sickness funds (SSFs) to develop disease management and IC (Health Care 
Modernization Act, 2004; Greb et al., 2006). Along with mildly competitive conditions 
to which SSFs have been subjected by politics (Thomson et al., 2013, Göpffarth and 
Henke, 2013), political initiatives are more likely to result in incremental innovations 
which remain limited to companies and service areas, thus having no effect on the 
system as a whole (Gibis and Steiner, 2014). 
The lack of a widespread implementation of IC in Germany led to a new legal initiative 
in form of the Innovation Fund (IF). The aim of this viewpoint is to introduce the IF as 
a policy instrument, and to outline its effectiveness on fostering integrated care, its 
limitations, and its reception to the international reader. 
Design of the Innovation Fund
In 2015, the German parliament passed the Health Care Strengthening Act (GKV-
Versorgungsstärkungsgesetz; Milstein and Blankart, 2016), primarily aiming at 





























































Journal of Health Organization and M
anagem
ent4
lowering costs and/or improving the quality of care by means of better integration, 
mainly across manifested sectors of health care (primary, secondary, home care) as 
well as health care professions. A key instrument to help implement the objective of 
the bill is the Innovation Fund (IF) (§§ 92a-92b Social Insurance Code Book V). The IF 
provided start-up funding for IC models and evaluating health service research to the 
value of € 300 million per year for a period between 2016 and 2019 (see Table 1 for 
details; Amelung et al., 2017, Gemeinsamer Bundesausschuss, 2020b). For a second 
period, 2000 until 2024, the IF continued with funding of € 200 million p.a. up. The IF 
thus has incentivized – and continuous to do so – service providers, statutory sickness 
funds, and researchers to develop, implement and diffuse IC. After funding disease 
management and financing the start-up of IC (Greb et al., 2006), the IF is now the third 
major political initiative that aims to foster innovations in the health care system [see 
figure 1] within the last two decades. The present IF incorporates some important 
learnings from the rather modest success of the two former initiatives. 
To some extent, the IF resembles an instrument that was implemented as part of an 
earlier health reform (Health Care Modernization Act, 2004; Greb et al., 2006), in which 
start-up funds were only provided for IC. However, there are important differences 
between the two funding schemes: firstly, the body that decides on the provision of 
funding differs (from 2004-2008 the statutory sickness funds were in charge); secondly, 
the projects of the IF must have the potential for scaling, and the scientific evaluation 
of projects is now mandatory.
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Figure 1: Selection of German health care system reforms associated with the fostering of integrated care, innovation and digitalisation 
in health care between 2000 to 2020
.
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Table 1: Content and procedure of the German heath care Innovation Fund.
Funding 
volume
€ 300 million per year over the first funding period of four years 
(2016-2019), of which € 225 million were for developing integrated 
health care models including their evaluation, and € 75 million for 
outcomes and health service research projects;
€ 200 million per year over the second funding period of five years 









Innovative models of health care should
- be above the level of standard care provided presently by the 
statutory sickness funds
- improve cross-sectoral collaboration
- reduce intra- and inter-sectoral fragmentation
- involve given subject areas (e.g. telemedicine, geriatric care, the 
provision of care in rural areas, drug safety for multi-morbid 
patients)
- include the evaluation of the outcome of treatment
- have potential for scaling into standard care and its implementation
- be supported by at least one statutory sickness fund as a 
consortium or cooperating partner
- project the duration, with a maximum funding period of 3.5 years
Time 
schedule
Regular calls (April 2016, May 2016, February 2017, October 2018, 
December 2019, to be continued annually)
Code of 
procedure
- Decisions on grants are made by the Innovation Committee, a 
subcommittee of the Joint Federal Committee (Gemeinsamer 
Bundesausschuss), consisting of ten members who represent 
providers, payers, and government officials of the Federal Ministry of 
Health and the Federal Ministry of Education and Research. 
- Advisory board of experts from academia and care providers 
review grant applications and recommend funding
- Project supervision by the DLR (German Aerospace Center) 
project management agency
Effectiveness of the Innovation Fund on Integrated Care Initiatives
1. Funded Projects of Integrated Care
To date, a total of 551 health care models and 913 health service research projects 
have been applied for, 380 have been funded with a total of 1,056.6 million Euro 
(Gemeinsamer Bundesausschuss, 2020b). Overall 150 positive decisions were made 
on applications that promote integrated care within health care. These IC models differ 
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greatly in terms of the breadth of integration (e.g. defined clinical groups, SSFs 
participating, or a circumscribed region), the depth of integration (number of sectors, 
number of professions), and the financial and organisational integration (from joint 
organisation to complete budget responsibility). None of the models works at a 
population level yet. Besides IC, a second focus of the funded models was on health 
care innovations to improve health care in rural or in structurally weak regions. Beyond 
this, various models aim to develop digital solutions in health care and foster digital 
infrastructure such as telemedical cooperation networks, electronic medical records or 
teleconsultations. 
Overall 230 health service research projects were funded, a substantial number of 
which dealt with quality assurance and improvement in health care and with the 
advancement of patient safety. In addition, studies addressed needs-based health care 
and efficiency of health care within the SSF-system. They examined the use and linking 
of routine data to improve care as well as the linking of health data at patient and 
population level. 
In view of several calls the framework conditions a d processes of the IF have been 
firmly established. Based on the recommendations of the advisory board of experts 
(Blettner et al., 2018) and a formalised and competitive application procedure, there 
was an incentive to develop study protocols that could be published internationally 
(Kuss et al., 2018, Koch et al., 2018). The first five projects in the area of health 
services research have been completed and the results, including recommendations 
for the transfer of findings to standard care, were published by the Innovation 
Committee (Gemeinsamer Bundesausschuss, 2020a). 
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2. Stakeholders Perspective on the Innovation Funds
While there is an obligation to evaluate the IC models funded by the IF to generate 
evidence of effectiveness, the IF itself is accompanied by way of three assessment 
studies. A first (Delphi-) study, which aimed to capture the perspective of the many 
stakeholders involved, included representation from SSFs, health and research policy, 
patient repr sentatives, healthcare providers, and scientists. It explored the 
perspective of the stakeholders to recommend how the Innovation Committee should 
allocate funds effectively, efficiently, justly, transparently and sustainably (Schmitt et 
al., 2015). 
A second study to assess the fund as a policy instrument as such was initiated by the 
legislative body itself. An interim report was published in 2019 for the German Federal 
Parliament (Die Bundesregierung der Bundesrepublik Deutschland, 2019) to provide 
parliamentarians with a basis on which to decide whether or not to extend the Fund. 
The report identified that the main disadvantage of the IF was the uncertainty that 
successful models and projects would be incorporated into regular care. On the one 
hand, a structured process of how to do this has ot been legally anchored; on the 
other hand, the funding decisions are made by the representatives of the established 
associations. This harbours the danger that decision-makers might place association 
policy calculations above the evidence generated in the model evaluations and thus 
render the introduction of potentially disruptive innovations into the health care system 
unlikely, if not impossible. There was also criticism that IC models were only developed 
within the health care system, and not being incorporated into other social insurance 
code books such as social welfare. The evaluation identified that insufficient flexibility 
was available for projects during their funding period, necessitating considerable 
administrative effort. The report therefore recommended for the second funding period 
that stakeholders from outside the health care self-governance system should be 
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included in order to structure the transfer process into routine care, to enhance 
transparency of the peer-review and decision process of the applications, and to 
strengthen the focus on non-physician professions according to their role in the health 
care system and support their applications (Die Bundesregierung der Bundesrepublik 
Deutschland, 2019). Indeed, the second funding period of the IF began in 2020 with a 
consultation process initiated publicly by the Innovation Committee and addressing 
various stakeholders, in addition, a pool of experts was formed (Gemeinsamer 
Bundesausschuss, 2020a). 
The third, a process study, which accompanied the legislative initiatives with three 
cross-sectional surveys, captured how the SSFs engaged in and appraised IC within 
the framework of new legislation (Göckler, 2017, Gersch et al., 2012, Gersch et al., 
2010). Predominant reasons for submitting proposals to the IF were improving the 
quality and efficiency of care. Large SSFs (> 1 million insured persons) in contrast to 
small SSFs evaluated the IF as being useful for innovation generation and to foster 
digitalization of health care. SSF representatives, nevertheless, complained of the low 
transparency of the application process fearing that political influence could be 
concealed behind a non-transparent decision-making process as the reviews of the 
external referees were not communicated. Writing a proposal was considered to be 
challenging, and the effort required for developing an evaluation concept and 
coordinating with health care providers as well as the application was rated as being 
high (Göckler, 2017). Since only some of the 113 health insurance funds existing in 
2017 participated, a bias towards the participation of those funds active in IC cannot 
be ruled out.
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Discussion - The Effectiveness of German Legal Measures to Strengthen 
Integrated Health Care
Not many of the IC models in the start-up funding period between 2004 and 2008 
proved to be sustainable, as many lacked a sustainable business model for the time 
after the start-up funding (Amelung et al., 2015). Other IC contracts seem to have 
served as a legitimacy façade to get money back that was mandated to the start-up 
financing (Auschra, 2017). In addition, the initially lacking scientific evaluation of the 
models limited the long-term effect of this policy instrument as well. In sum, the 
significance of IC continued to be negligible for SSFs (below 1% of the yearly budget), 
and only few of them engaged in IC.
The IF, in contrast, provides incentives to develop a large number of IC models and 
serves as an impulse for SSFs to engage and to collaborate with health service 
providers. The broad scope of the funding conditions leads to new developments not 
only in the field of IC, but also beyond it in the areas of digitalisation, health care 
coverage or quality of care, and thus exerts a more general innovation-promoting 
effect. 
Secondly, the linking of a funding approval with the potential for scaling up to standard 
care should ensure significantly more sustainability in the design of the IC models. 
However, this remains unclear once the IF comes to an end, because a structured 
transfer process into routine care does not yet exist. As long as the Innovation 
Committee does not pass regulation to that effect, the SSFs de facto decide on any 
interim financing of a model which was positively evaluated or a model must be costly 
rebuilt to the original standard care (Reinhardt, 2018). 
Thirdly, the IF provides for a mandatory evaluation of all new models and thus for the 
first time promotes the generation of evidence in health care research, a novelty in the 
context of legislative initiatives in Germany. However, the need for positive evaluation 
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for upscaling into standard care might put pressure on the evaluators and could thus 
undermine scientific neutrality.
The IF might not support the dissemination of disruptive innovations though (Kleinke 
et al., 2009). Instead, the IF may only add to the scaling of previously developed 
prototypes, thereby favouring incremental innovations, driven by a few very committed 
active SSFs which, however, are continuously growing in number (Gersch and Sydow, 
2017).
The IF’s innovation effect could possibly be better exploited if all applications, including 
those that were rejected, were made public. The same applies to the peer review of all 
applications and the decision history and discussion in the Innovation Committee on 
which approval or rejection is based. The abundance of applications to the IF contains 
much more innovative potential if the rejected models are considered as well 
(Stegmaier and Roski, 2019). 
Conclusions and Policy Implications
The IF is an example of decisive legislative action to promote integration in a health 
care system which, due to its self-governing structure in Germany, tends to be rather 
persistent and less effective in promoting innovation than centrally managed health 
care systems. Thus, lessons learned from its effects, acceptance, and limitations are 
of interest to all health care systems that are characterized by self-administration 
structures and a multitude of stakeholders involved in provision of health care, such as 
countries with Bismarck-type health care systems or the USA. 
The accompanying assessments of the IF shows, that first, a policy instrument such 
as funding innovation should rely on a transparent application process. Second, the 
effort required for funding application ought to be simplified. Third, mandatory 
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evaluation seems helpful to create a national knowledge base on the effectiveness and 
efficiency of IC models.
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